These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17259205)

  • 1. Lorazepam induces multiple disturbances in selective attention: attentional overload, decrement in target processing efficiency, and shifts in perceptual discrimination and response bias.
    Michael GA; Bacon E; Offerlin-Meyer I
    J Psychopharmacol; 2007 Sep; 21(7):691-9. PubMed ID: 17259205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of single doses of alpidem, lorazepam, and placebo on memory and attention in healthy young and elderly volunteers.
    Satzger W; Engel RR; Ferguson E; Kapfhammer H; Eich FX; Hippius H
    Pharmacopsychiatry; 1990 May; 23 Suppl 3():114-9. PubMed ID: 1974070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diazepam impairs temporal dynamics of visual attention.
    Boucart M; Waucquier N; Michael GA; Libersa C
    Exp Clin Psychopharmacol; 2007 Feb; 15(1):115-22. PubMed ID: 17295590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of benzodiazepines on structural and conceptual/lexical priming.
    Boucart M; Biederman I; Cuervo C; Danion JM; Wagemans J
    Psychopharmacology (Berl); 2002 Dec; 165(1):43-50. PubMed ID: 12474117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lorazepam and oxazepam on perceptual and procedural memory functions.
    Martin J; Matthews A; Martin F; Kirkby KC; Alexander J; Daniels B
    Psychopharmacology (Berl); 2002 Nov; 164(3):262-7. PubMed ID: 12424549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lorazepam on visual perceptual abilities.
    Pompéia S; Pradella-Hallinan M; Manzano GM; Bueno OF
    Hum Psychopharmacol; 2008 Apr; 23(3):183-92. PubMed ID: 18318455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in response to lorazepam in a human drug discrimination study.
    Jackson A; Stephens D; Duka T
    J Psychopharmacol; 2005 Nov; 19(6):614-9. PubMed ID: 16272183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem-completion tasks (indirect, direct inclusion and exclusion) are differently affected by equipotent doses of lorazepam and flunitrazepam.
    Pompéia S; Bueno OF; Galduróz JC; Tufik S
    Hum Psychopharmacol; 2003 Oct; 18(7):541-9. PubMed ID: 14533136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prefrontal cortex lesions and scopolamine impair attention performance of C57BL/6 mice in a novel 2-choice visual discrimination task.
    Dillon GM; Shelton D; McKinney AP; Caniga M; Marcus JN; Ferguson MT; Kornecook TJ; Dodart JC
    Behav Brain Res; 2009 Dec; 204(1):67-76. PubMed ID: 19416740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual tracking following lorazepam or pentobarbital.
    Stoller KP; Belleville JP; Bellville JW
    Anesthesiology; 1976 Nov; 45(5):565-8. PubMed ID: 9847
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of gonadectomy and androgen supplementation on attention in male rats.
    Johnson RT; Burk JA
    Neurobiol Learn Mem; 2006 May; 85(3):219-27. PubMed ID: 16330230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A alpha2,3 selective agonist, in comparison with lorazepam in healthy volunteers.
    de Haas SL; Franson KL; Schmitt JA; Cohen AF; Fau JB; Dubruc C; van Gerven JM
    J Psychopharmacol; 2009 Aug; 23(6):625-32. PubMed ID: 18635696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA(A) alpha2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers.
    de Haas SL; de Visser SJ; van der Post JP; Schoemaker RC; van Dyck K; Murphy MG; de Smet M; Vessey LK; Ramakrishnan R; Xue L; Cohen AF; van Gerven JM
    J Psychopharmacol; 2008 Jan; 22(1):24-32. PubMed ID: 18187530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smooth pursuit eye movements and perception share target selection, but only some central resources.
    Kerzel D; Born S; Souto D
    Behav Brain Res; 2009 Jul; 201(1):66-73. PubMed ID: 19428618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between effects of caffeine and lorazepam in performance tests and self-ratings.
    File SE; Bond AJ; Lister RG
    J Clin Psychopharmacol; 1982 Apr; 2(2):102-6. PubMed ID: 6122694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Choice reaction time (CRT) in humans after administration of lorazepam].
    Lombardi M; Cosi V
    Boll Soc Ital Biol Sper; 1979 Jan; 55(2):171-6. PubMed ID: 17955645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of lorazepam on brain activity pattern during an anxiety symptom provocation challenge.
    Schunck T; Mathis A; Erb G; Namer IJ; Demazières A; Luthringer R
    J Psychopharmacol; 2010 May; 24(5):701-8. PubMed ID: 19460871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of lorazepam on vision and oculomotor balance.
    Speeg-Schatz C; Giersch A; Boucart M; Gottenkiene S; Tondre M; Kauffmann-Muller F; Danion JM
    Binocul Vis Strabismus Q; 2001; 16(2):99-104. PubMed ID: 11388882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of pharmacologically-induced attentional impairment by methylphenidate in rats.
    Rezvani AH; Kholdebarin E; Cauley MC; Dawson E; Levin ED
    Pharmacol Biochem Behav; 2009 Mar; 92(1):141-6. PubMed ID: 19041337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lorazepam impairs both visual and auditory perceptual priming.
    Vidailhet P; Danion JM; Chemin C; Kazès M
    Psychopharmacology (Berl); 1999 Dec; 147(3):266-73. PubMed ID: 10639684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.